Literature DB >> 2011526

Phosphorothioate-containing RNAs show mRNA activity in the prokaryotic translation systems in vitro.

T Ueda1, H Tohda, N Chikazumi, F Eckstein, K Watanabe.   

Abstract

Phosphorothioate-containing RNAs were generated by transcription of coliphage T7 DNA using the Sp diastereomers of ribonucleoside 5'-O-(1-thiotriphosphates) and T7 RNA polymerase. RNAs in which a single nucleotide was substituted by the corresponding nucleoside phosphorothioate functioned as mRNA in the cell-free translation systems prepared from Escherichia coli and from an extreme thermophilic bacterium, Thermus thermophilus. This substitution increased the efficiency of protein synthesis by stabilizing the mRNAs in these systems. As the proportion of substituted nucleotides was increased, their mRNA activity was decreased accordingly. As judged from the analysis by SDS-polyacrylamide gel-electrophoresis, the proteins synthesized using phosphorothioate-containing mRNAs as template were identical to those obtained with unsubstituted mRNAs. However, larger proteins which were barely detectable when unsubstituted mRNA was used were well represented when phosphorothioate-RNA was used instead. The advantages in using the phosphorothioate-mRNAs in the in vitro translation systems are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2011526      PMCID: PMC333646          DOI: 10.1093/nar/19.3.547

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

Review 1.  Nucleoside phosphorothioates.

Authors:  F Eckstein
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

2.  Stereospecificity of nucleases towards phosphorothioate-substituted RNA: stereochemistry of transcription by T7 RNA polymerase.

Authors:  A D Griffiths; B V Potter; I C Eperon
Journal:  Nucleic Acids Res       Date:  1987-05-26       Impact factor: 16.971

3.  The antiviral activity of thiophosphate-substituted polyribonucleotides in vitro and in vivo.

Authors:  E CDe Clercq; F Eckstein; H Sternbach; T C Merigan
Journal:  Virology       Date:  1970-10       Impact factor: 3.616

4.  Analysis of the 5'-terminal nucleotide sequences of ribonucleic acids 1. the 5'-termini of Excherichia coli ribosomal RNA.

Authors:  M Takanami
Journal:  J Mol Biol       Date:  1967-01-28       Impact factor: 5.469

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Cloning and expression of the gene for bacteriophage T7 RNA polymerase.

Authors:  P Davanloo; A H Rosenberg; J J Dunn; F W Studier
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Complete nucleotide sequence of bacteriophage T7 DNA and the locations of T7 genetic elements.

Authors:  J J Dunn; F W Studier
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

8.  Identification of a non-junction phosphodiester that influences an autolytic processing reaction of RNA.

Authors:  J M Buzayan; H van Tol; P A Feldstein; G Bruening
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

9.  Purification and thermal stability of several amino acid-specific tRNAs from an extreme thermophile, Thermus thermophilus HB8.

Authors:  K Watanabe; T Oshima; K Iijima; Z Yamaizumi; S Nishimura
Journal:  J Biochem       Date:  1980-01       Impact factor: 3.387

10.  Studies on the toxicity and antiviral activity of various polynucleotides.

Authors:  D R Black; F Eckstein; E DeClercq; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

View more
  9 in total

Review 1.  Non-natural nucleic acids for synthetic biology.

Authors:  Daniel H Appella
Journal:  Curr Opin Chem Biol       Date:  2009-10-29       Impact factor: 8.822

2.  Structure of 5S rRNA within the Escherichia coli ribosome: iodine-induced cleavage patterns of phosphorothioate derivatives.

Authors:  O V Shpanchenko; O A Dontsova; A A Bogdanov; K H Nierhaus
Journal:  RNA       Date:  1998-09       Impact factor: 4.942

3.  In vitro analysis of roles of a disulfide bridge and a calcium binding site in activation of Pseudomonas sp. strain KWI-56 lipase.

Authors:  J Yang; K Kobayashi; Y Iwasaki; H Nakano; T Yamane
Journal:  J Bacteriol       Date:  2000-01       Impact factor: 3.490

4.  Interaction of mRNA with the Escherichia coli ribosome: accessibility of phosphorothioate-containing mRNA bound to ribosomes for iodine cleavage.

Authors:  E V Alexeeva; O V Shpanchenko; O A Dontsova; A A Bogdanov; K H Nierhaus
Journal:  Nucleic Acids Res       Date:  1996-06-15       Impact factor: 16.971

5.  Nuclease resistance of an extraordinarily thermostable mini-hairpin DNA fragment, d(GCGAAGC) and its application to in vitro protein synthesis.

Authors:  S Yoshizawa; T Ueda; Y Ishido; K Miura; K Watanabe; I Hirao
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

6.  Use of a novel 5'-regioselective phosphitylating reagent for one-pot synthesis of nucleoside 5'-triphosphates from unprotected nucleosides.

Authors:  Julianne Caton-Williams; Rudiona Hoxhaj; Bilal Fiaz; Zhen Huang
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2013-03

7.  A reproducible and scalable procedure for preparing bacterial extracts for cell-free protein synthesis.

Authors:  Kazushige Katsura; Takayoshi Matsuda; Yuri Tomabechi; Mayumi Yonemochi; Kazuharu Hanada; Noboru Ohsawa; Kensaku Sakamoto; Chie Takemoto; Mikako Shirouzu
Journal:  J Biochem       Date:  2017-11-01       Impact factor: 3.387

8.  Phosphodiester modifications in mRNA poly(A) tail prevent deadenylation without compromising protein expression.

Authors:  Dominika Strzelecka; Miroslaw Smietanski; Pawel J Sikorski; Marcin Warminski; Joanna Kowalska; Jacek Jemielity
Journal:  RNA       Date:  2020-08-20       Impact factor: 4.942

Review 9.  The Pivotal Role of Chemical Modifications in mRNA Therapeutics.

Authors:  Albert Liu; Xiao Wang
Journal:  Front Cell Dev Biol       Date:  2022-07-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.